Invention Grant
- Patent Title: HCV protease inhibitors and uses thereof
- Patent Title (中): HCV蛋白酶抑制剂及其用途
-
Application No.: US12492518Application Date: 2009-06-26
-
Publication No.: US08497275B2Publication Date: 2013-07-30
- Inventor: Brian E. Green , David D. Anderson , Todd D. Bosse , Curt S. Cooper , Larry L. Klein , Allan C. Krueger , Daniel P. Larson , Dachun Liu , Keith F. McDaniel , Christopher E. Motter , John K. Pratt , Todd W. Rockway , Teresa A. Rosenberg , Ming C. Yeung , Hui-Ju Chen , Jason P. Shanley
- Applicant: Brian E. Green , David D. Anderson , Todd D. Bosse , Curt S. Cooper , Larry L. Klein , Allan C. Krueger , Daniel P. Larson , Dachun Liu , Keith F. McDaniel , Christopher E. Motter , John K. Pratt , Todd W. Rockway , Teresa A. Rosenberg , Ming C. Yeung , Hui-Ju Chen , Jason P. Shanley
- Applicant Address: US IL North Chicago
- Assignee: AbbVie Inc.
- Current Assignee: AbbVie Inc.
- Current Assignee Address: US IL North Chicago
- Agent Bradley E. Davis
- Main IPC: A61K31/4965
- IPC: A61K31/4965 ; A61K31/40 ; A61K38/00 ; A61K38/05
Abstract:
This invention relates to: (a) compounds of formula I and salts thereof that, inter alia, are useful as hepatitis C virus (HCV) inhibitors; (b) intermediates useful for the preparation of such compounds and salts; (c) pharmaceutical compositions comprising such compounds and salts; and (d) methods of use of such compounds, salts, and compositions.
Public/Granted literature
- US20100029686A1 HCV PROTEASE INHIBITORS AND USES THEREOF Public/Granted day:2010-02-04
Information query
